As a new study spotlights a growing role for LRRK2 in Parkinson’s, Denali clears an early trial hurdle
Hard on the heels of new research that points to a much wider role for LRRK2 in Parkinson’s disease than had earlier been believed, investigators …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
